 Isoniazid (INH) 
M. tuberculosis H37Ra overexpressing Rv2170 were found to be resistant to INH at minimum inhibitory concentrations that inhibited wildtype strains. In addition, intracellular M. tuberculosis H37Ra overexpressing Rv2170 survived better in macrophages when treated with INH. Our results strongly indicate that Rv2170 acetylates INH, and this could be one of the strategies adopted by at least some M. tuberculosis strains to overcome INH toxicity.
For centuries tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), has been one of the top reasons for death of humans. WHO reports that 1.3 million people died due to TB in 2017 (1) . TB is generally treated with first-line drugs isoniazid, rifampicin, ethambutol, and pyrazinamide (2) . Infection by MTB resistant to at least isoniazid and rifampicin leads to multidrug-resistant (MDR) TB. Treatment of MDR-TB is more difficult and costlier than treatment of drug-susceptible TB, and the drugs cause severe side effects in patients.
Isoniazid (INH) is a potent anti-TB molecule and the killing of MTB is triggered when KatG enzyme of MTB activates the prodrug INH by coupling it with NADH. The activated INH inhibits InhA protein by binding to its active site which in turn hinders mycolic acid synthesis, thereby disturbing the cell wall biosynthesis of MTB (3) . Mutations at codon 315 of katG and the promoter region of inhA genes are often observed in INH resistant MTB. The extent of mutation in katG (~72%) and inhA (~18%) strongly depends on the genomic region as well as on the ethnic background of the patient (4) . INH resistant strains with mutations in genes other than katG and inhA have also been identified and these genes include ahpC, kasA and ndh (5) . Interestingly, about 10% of INH resistant strains do not have mutations in any of these genes (6) , which suggests that these strains may have mutations in other genes or they may adopt some other strategies to counter INH.
Mechanisms by which drug resistant pathogens achieve antimicrobial resistance include degradation or modification of drugs, modification of the targets of drugs, and altering the permeability of bacterial membrane towards those drugs (7) . Drug resistant pathogens often possess specialized enzymes which can modify or degrade drugs (8) . Acetylation is one of the well-known mechanisms adopted by bacteria to modify drugs as well as drug targets (9) . In our laboratory we have isolated an acetyltransferase, Rv3423.1, from MTB H37Rv strain which was shown to acetylate histone H3 (10) . Subsequent analysis of MTB genome using the MycoBrowser portal (https://mycobrowser.epfl.ch/) revealed the presence of 11 more genes capable of coding for acetyltransferases. Bacterial proteins under GCN5-related N-acetyltransferases family are shown to be involved in drug resistance (11) . We cloned two of the putative acetyltransferases (Rv0428c and Rv2170) with N-acetyltransferase domain and checked the histone acetyltransferase activity of the purified enzymes. However, we could not find any histone acetyltransferase activity for these proteins. At this point we wondered if they could be involved in the acetylation of other substrates. Many of the drugs used in the treatment of human diseases are known to be acetylated by liver enzymes. Isoniazid (INH), a first-line anti-TB drug, is known to be acetylated in the liver and gastrointestinal tract of patients to form N-acetyl INH which is further broken down into isonicotinic acid and acetylhydrazine (12) . We hypothesized that MTB may employ a similar mechanism, at least in some cases, to detoxify INH. To test our proposition we checked the ability of the purified enzymes to acetylate INH in vitro.
Results

Purified Rv2170 is able to acetylate isoniazid
Rv2170 and Rv0428c were cloned into pET32a vector and heterologously expressed in E. coli Rosetta BL21(DE3) strain. As the recombinant proteins were His-tagged, purification was carried out by affinity chromatography using Ni-NTA agarose resin. The eluted protein fractions were checked and purity was confirmed by SDS-PAGE. Highly purified Rv2170 (23k Da) and Rv0428c (33 kDa) were observed in the gel. We confirmed the identity of the purified proteins by western blot using His tag monoclonal antibody ( Fig  1A and 1B) . The acetyltransferase activity of these putative acetyltransferases was checked by fluorometric assay using INH as substrate. Rv2170 exhibited significant acetyltransferase activity ( Fig 1C) , whereas Rv0428c did not show any activity, and therefore Rv2170 was selected for further studies.
Isoniazid treated with Rv2170 protein failed to kill M. smegmatis
By REMA we observed that the minimum inhibitory concentration (MIC) of INH against M. smegmatis was 8 µg/mL, as reported earlier (13) . To test if modified INH inhibits M. smegmatis, the bacteria were treated with the reaction mixture (INH acetylated with Rv2170 in vitro) to analyze its sensitivity towards acetylated INH. REMA results (Fig 2A) clearly indicated that M. smegmatis remained viable when the cells were incubated with INH treated with Rv2170 (test) whereas M. smegmatis treated with the control (the same concentration of INH without Rv2170) were killed. The same has been proven by LIVE/DEAD assay also. Confocal microscopy ( Fig 2B) and the ratio of green to red fluorescence ( Fig 2C) confirmed that Rv2170 rendered INH inactive. The ratio obtained for untreated M. smegmatis was 5.108 ± 0.097, whereas for the bacteria treated with INH (control) the ratio decreased to 2.405 ± 0.09. However, when M. smegmatis was treated with acetylated INH (test) the ratio increased to 3.865 ± 0.298, strongly suggesting that Rv2170 effectively inactivates INH and hence the bacteria retained their viability. Rifampicin was used as the positive control for both REMA (1 µg/mL) and LIVE/DEAD assays (2 µg/mL). LIVE/DEAD assay performed with the end products, isonicotinic acid and acetylhydrazine, showed that these compounds were not toxic to the bacteria (Supplementary Figure 1 ).
Acetylated isoniazid gets broken down into isonicotinic acid and acetylhydrazine
LC-MS analysis of the reaction mixture of INH (160 µg/mL) treated with Rv2170 (500 nM) in vitro revealed the presence of four compounds, whereas in the control a single peak was detected ( Fig 3A) . The molecular masses of three peaks INH (137.13), isonicotinic acid -INA (123.11) and acetylhydrazine -AH (74.08) were confirmed by running the respective standard molecules under the same conditions. Interestingly the fourth peak represented a molecular mass of 179.20 which very closely matched with the molecular mass of the intermediate compound acetylisoniazid -AcINH (C8H9N3O2 -179.18). We performed HPLC analysis and the peaks in chromatograms of control and reaction mixture were identified by comparing the retention time of authentic standard molecules (INH-2.492 min, INA-3.208 min, AH-3.610 min) and confirmed by spiking the reaction mixture with them ( Fig 3B and 3C ). Thus these results support our hypothesis that Rv2170 acetylates INH, and the product gets broken down into INA and AH.
MSMEG_4238 -the orthologous protein of Rv2170 in M. smegmatis is less efficient in acetylating isoniazid
MSMEG_4238 is the orthologous protein of Rv2170 in M. smegmatis. We heterologously expressed the gene in E. coli and purified MSMEG_4238 and analysed its acetylation efficacy in comparison with that of Rv2170. Supplementary Fig 2] . The ratio obtained for untreated M. smegmatis was 5.096 ± 0.0781, whereas for M. smegmatis treated with INH (control) the ratio decreased to 2.536 ± 0.185. However, when M. smegmatis was treated with INH acetylated with Rv2170 (test 1) the ratio increased to 4.029 ± 0.109, and that for INH acetylated with MSEMG_4238 (test 2) increases marginally to 2.872 ± 0.157 showing that MSEG_4238 is less effective than Rv2170 protein in acetylating INH. We quantified the extent of acetylation of INH from the area of the peaks in the HPLC chromatograms [ Fig  4(D) ]. When Rv2170 was used for acetylation, the INH concentration declined to 4.004 ± 0.243 µg/mL from 15.302 ± 0.410 µg/mL (control), whereas for MSMEG_4238 the INH concentration came down only to 11.486 ± 1.310 µg/mL. The better activity of Rv2170 than of MSMEG_4238 is reflected in the formation of the degradation products also. The quantification results showed that acetylation of INH catalysed by Rv2170 leads to the production of more INA and AH (6.815 ± 0.027 and 1.547 ± 0.017 µg/mL, respectively), which was significantly high when compared to the activity of MSMEG_4238 (INA -4.058 ± 0.257 µg/mL and AH -0.340 ± 0.01 µg/mL). Thus the results obtained from these data clearly show that MSMEG_4238 is less effective than Rv2170 in acetylating INH.
INH binds better to Rv2170 than to MSMEG_4238
We aligned the amino acid sequences of Rv2170 and MSMEG_4238 proteins using CLUSTAL O (1.2.4) and found that there are substitutions of 30 amino acids in the latter [ Fig. 5 (A)]. Change in structure due to the differences in amino acids may have affected the acetylation efficacy of this enzyme. BLAST search yielded the most appropriate template (PBD 1U6M) of the crystal structure of acetyltransferase with a resolution of 2.4 Å which served as the best template for building the 3D structure of Rv2170 and MSMEG_4238. They were modelled using SWISS MODEL using the template -1u6m.1.A acetyltransferase of GNAT family from Enterococcus faecalis. The best-docked conformation showed that INH interacts with Rv2170 and MSMEG_4238 through hydrogen bond interactions and the drug is entirely buried in the interior of the binding pocket with its heterocyclic ring pointing towards the outer region [ Figure 5 (B & C)]. The binding energy clearly showed that INH has better affinity towards Rv2170 (-5.329 kcal/mol) than to MSMEG_4238 (-4.593 kcal/mol).
M. smegmatis and M. tuberculosis H37Ra overexpressing Rv2170 are resistant to INH
The MIC values for INH against M. smegmatis and MTB were determined to be 8 and 0.5 µg/mL, respectively (Supplementary figure 3 and 4) which matched with the concentrations reported earlier (14, 15) . To assess whether the enzyme offers any survival advantage to M. smegmatis and MTB H37Ra in the presence of INH, we overexpressed Rv2170 in these bacteria. The recombinant strains were exposed to INH (final concentration 8 and 0.5 µg/mL, for M. smegmatis and MTB H37Ra, respectively) and then performed REMA, LIVE/DEAD assay and CFU count. Bacteria carrying empty pBEN vector served as control. REMA results clearly showed that the recombinant M. smegmatis survived INH (8 µg/mL) toxicity whereas M. smegmatis carrying empty vector succumbed to the drug toxicity ( Fig 6A) . This was also evident from fluorescent data ( Fig 6B) and LIVE/DEAD confocal analysis ( Fig 6C) . The green to red ratio obtained for M. smegmatis (vector control) treated with INH was 2.468 ± 0.091, and 3.868 ± 0.047 for recombinant M. smegmatis suggesting that M. smegmatis overexpressing Rv2170 can resist INH toxicity.
Recombinant MTB H37Ra strain expressing Rv2170 retained its viability after treating with INH whereas the vector-alone control did not. REMA results ( Fig 7A) showed that the recombinant MTB effectively resisted INH (0.5 µg/mL) when compared to the vector-alone control. Green to red fluorescence ratio ( Fig 7B) for MTB (vector control) treated with INH was 1.436 ± 0.056 and it was 3.434 ± 0.252 for the recombinant bacterium, which clearly showed that MTB that overexpressed Rv2170 could resist INH toxicity. Results from CFU assay also showed that MTB overexpressing Rv2170 could effectively survive INH toxicity ( Fig 7C) . When MTB (vector control) was treated with INH the log CFU obtained was 3.611 ± 0.038 while the number increased significantly (5.316 ± 0.270) when recombinant MTB was treated with INH.
M. tuberculosis H37Ra overexpressing Rv2170 showed better intracellular survival in macrophages treated with INH
To analyse whether the protein offers any protective advantage to the intracellular bacteria in the presence of INH, THP-1 cells infected with MTB H37Ra overexpressing Rv2170 or carrying empty vector were treated with INH for 24 h. The CFU counts obtained revealed that INH fails to kill intracellular recombinant MTB overexpressing Rv2170. The survival percentage ( Fig 7D) of recombinant MTB (64.82 ± 5.05%) was significantly higher than that of MTB vectoralone control (45.54 ± 3.09%) suggesting that overexpression of Rv2170 in MTB enhances its survival in macrophages in the presence of INH.
Discussion
Multidrug resistant strains of M. tuberculosis tolerate the key first-line drugs isoniazid and rifampicin and this has negatively impacted the tuberculosis control programs globally (16) . According to WHO report the average of isoniazid resistance is 7.2% in new TB cases, and 11.6% in previously treated TB cases (17) . INH resistance mainly arises due to mutations in target genes katG, inhA, ahpC, kasA and ndh (18) . In humans INH is readily absorbed by the gastrointestinal tract and is metabolized by N-acetyltransferases (NAT 2) present in liver and gastrointestinal tract into isonicotinic acid (INA) and acetylhydrazine (AH) (19) . Many laboratories have reported INH resistant MTB strains with no known mutations (20, 21, 22) suggesting possible existence of other strategies to survive in the presence of INH. This made us wonder if acetyltransferases in MTB, like NAT2 of liver and gastrointestinal tract, can also inactivate INH by acetylation.
Acetylation is one of the widely adopted strategies of pathogens to deactivate drugs such as aminoglycosides, chloramphenicol, streptogramins, and fluoroquinolones (23) . Chloramphenicol acetyltransferases that acetylate choramphenicol resulting in chloramphenicol resistance in bacteria have been extensively reviewed by Schwarz et al (24) . Riemerella anatipestifer causing serositis and septicaemia in poultry are reported to show resistance towards chloramphenicol by acetylation mechanism (25) . Eis protein of MTB is reported to be involved in the deactivation of capreomycin by acetylation (26) . Arylamine N-acetyltransferase of MTB has been reported to acetylate p-aminosalicylic acid leading to its inactivation (27) .
We screened two probable acetyltransferases of MTB (Rv0428c and Rv2170) with N-acetyltransferase domain for their ability to acetylate INH. A proprietary fluorometric assay was performed to analyse the transfer of acetyl group of acetyl CoA to INH, and the CoA released during the reaction is converted into a fluorescent product quantity of which indirectly indicates the acetylation activity. The results clearly showed that Rv2170 has the ability to acetylate INH.
Since liquid chromatography coupled with mass spectrometry is widely used in the identification of drugs and their degradation products (28) Figure 5 and 6 ). This suggests a possibility that Rv2170 and its orthologous proteins in pathogenic mycobacteria at some point of time evolved into a virulence factor, and the pathogenic bacteria became a separate group during evolution. The ScanProsite analysis (30) of functional domains showed that amino acids from 44-205 and 31-204 form the GNAT conserved domain for Rv2170 and MSMEG_4238, respectively. Alignment of amino acids of Rv2170 and MSMEG_4238 showed 30 non-conserved substitutions in the conserved domain; for example Leu105 and Thr203 of Rv2170 are substituted by Ser and Pro in MSMEG_4238, respectively. The difference in amino acids may have altered the protein conformation of MSEMG_4238 which most likely resulted in the reduced affinity of INH for the protein.
We carried out docking analysis to verify the binding efficiencies of INH to Rv2170 and MSMEG_4238. As the number of hydrogen bonds is an important factor influencing protein stability and function, hydrogen bond occupancies at a distance cutoff of 3.5 Å and an angle cut-off of 30° were applied in the calculation of hydrogen bonds. The -NH2 and C=O functional groups of isoniazid form strong hydrogen bond interactions with the binding site residues of the protein. The proposed INH acetylation reaction catalysed by Rv2170 is shown in Figure 8 . However, how acetylisoniazid gets converted into INA and AH is not clear from our study. Since this is a hydrolysis reaction (AcINH + H2O → INA + AH), the reaction probably will be catalysed by any one of the hydrolase enzymes present in MTB which is yet to be identified. Taken together, our results suggest that Rv2170-mediated acetylation of INH is a novel strategy adopted by at least some of the INH resistant MTB strains. Table 1 ). The PCR products were purified and were cloned into a pET32a vector using Nde1 and HindIII restriction sites. The resulting construct was then transformed into competent E. coli (JM109) cells. Ampicillin resistant clones were selected, and the recombinant plasmid was then transformed into competent E. coli BL21(DE3) Rossetta cells. Isopropyl β-D -1-thiogalactopyranoside (IPTG -1 mM) was used to induce expression of the genes. The over-expressed 6X Histagged fusion proteins were purified under native conditions using Ni-NTA agarose resin (Thermo Scientific, Waltham, MA, USA). The purified proteins were concentrated and buffer-exchanged using Amicon Ultra-15 centrifugal filter units (Millipore, Billerica, MA, USA) and stored in 20% glycerol at -20 °C for assays.
Experimental procedures
Acetyltransferase activity of Rv0428c and Rv2170 was determined using fluorometric acetyltransferase activity assay kit (ABCAM-ab204536, Cambridge, USA) and isoniazid (100 µM) as substrate. The assay was performed with recombinant protein (50 nM) according to manufacturer's instructions.
The in vitro acetylation assay was performed according to Kuninger et al. (31) with slight modification. In vitro acetylation reaction mixture contained isoniazid (16 µg/mL = 116.67 µM), acetyl CoA (116.67 µM) and protein (50 nM) in acetyltransferase buffer (50 mM Tris HCl -pH 8.0 and 10% glycerol). The reaction was performed for 45 min at 37 °C, and was terminated by adding 0.05% H2SO4. This reaction mixture was used as the source of INH in the bacterial viability assay and confocal analysis. For LC-MS and HPLC analyses we increased the concentration of the components of the in vitro acetylation reaction mixture by tenfold for better detection.
The reaction mixture after performing the in vitro acetylation assay was subjected to liquid chromatography-mass spectrometry (LC-MS) analysis. The analysis was carried out on a UHPLC LC-30A (Shimadzu, Japan) associated with a Triple Quadrupole Mass Spectrometer LCMS-8045. The instrument was equipped with solvent delivery pumps (LC-30AD), degassing unit (DGU-20A5R), auto sampler (SIL-30AC), column oven (CTO-30AC), system controller (CBM-20A), triple quadrupole mass spectrometer (LCMS8045) and LabSolutions Ver. 5.86 software for data analysis. The assay mixture was filtered (0.22 µm N66Posidyne positively charged zeta membrane, Pall Life Sciences) and injected into the column (Shim-pack GISS, 1.9 µM C18, 2.1×150 mm, Shimadzu). Methanol (70%) containing 0.1% formic acid was used as the mobile phase for the LC analysis followed by mass analysis of the compounds via electrospray ionisation (ESI)-MS in the scanning mode.
Chromatographic analysis of the reaction mixture and the reference compounds was performed using a Prominence UFLC system (Shimadzu, Japan) equipped with system controller (LC-20AD), C18 column (Phenomenex Gemini, 250 × 4.6 mm, 5 µm), column oven (CTO-20A), a Rheodyne injector (20 µL loop) and a diode array detector (SPD-M20A). Twenty microlitre of sample filtered through 0.45 µm PTFE filter was injected into the column and the column temperature was maintained at 33 °C. The run time was set to 8 min. For the detection of isoniazid and isonicotinic acid, a mixture of 40% acetonitrile and 60% phosphate buffer (20 mM di-sodium hydrogen phosphate and pH was adjusted to 4.5 with ortho phosphoric acid) was used as the mobile phase with a flow rate of 0.8 mL/min. For the determination of acetylhydrazine HPLC grade water was used as the mobile phase with a flow rate of 1 mL/min. The sample peaks were monitored at 260 nm (isoniazid and isonicotinic acid) and 206 nm (acetylhydrazine). The compounds in the in vitro acetylation assay mixture were analyzed by comparing with standard compounds using the retention time, and also by spiking the samples with standards. Quantities of compounds in the samples were determined from the standard calibration curves plotted with known quantities of authentic commercial molecules. LC LabSolutions software was used for data acquisition and analysis.
Resazurin microtitre assay (REMA) was performed as detailed by Martin et al. (32) . Bacterial viability was analysed by using LIVE/DEAD ® BacLight TM Bacterial viability kit (L7007 Molecular Probes, Invitrogen). The experiment was performed as per the manufacturer's instructions. The bacterial cells with reagent mixture were incubated at 37 °C in the dark for 15 min. After incubation fluorescence intensity was measured at 485/530 nm (green) and 485/630 nm (red) and the ratio intensities of green to red was calculated. Following this the bacteria were observed under confocal microscope (Nikon A1R equipped with Nikon Eclipse Ti-S inverted fluorescent microscope).
To infer the structure of Rv2170 and its orthologous protein MSMEG_4238 from M. smegmatis, we performed BLASTP (33) search of the Protein Data Bank (PDB) using the NCBI server (http://www.ncbi.nlm.nih.gov) with default parameters for identifying suitable templates for homology modelling. Among the five homology models of Rv2170 and MSMEG_4238 generated by using MODELLER 9v12 (34), the best model was selected based on PROCHECK analysis (35) and the possible best active site was determined using the CASTp web server (36) . The preparatory steps for docking studies were performed by utilising the software AutoDock Tools 4, and the grid box creation (37) for docking of ligands based on the predicted active site. All possible rotatable bonds and partial atomic charge distribution of the ligands were determined via Gasteiger methods, and the Kollman charges were assigned for all atoms of the receptor. In Autodock4.2 the structures were docked using the Lamarckian genetic algorithm with the docking parameters defined as follows: population size of 200, 100 docking runs, random starting position and conformation, mutation rate of 0.02, crossover rate of 0.8, translation step ranges of 2.0 Å, 2.5 million energy evaluations and local search rate of 0.06. The docking results <1.0 Å were clustered based on similarities in binding modes and affinities in each run discriminated by using their positional root-mean square deviation (RMSD), and represented with the most favourable free energy binding.
The Rv2170 gene was amplified from MTB H37Rv genomic DNA with the forward (Rv2170PBENF) and reverse (Rv2170PBENR) primers ( Supplementary  Table 1 ) containing BamHI and HindIII restriction sites, respectively. The gene was cloned into mycobacterial constitutive expression vector pBEN using the abovementioned restriction sites in the multiple cloning site downstream of the mycobacterial hsp60 promoter. Electroporation of M. smegmatis mc 2 155 and MTB H37Ra competent cells was performed using a Gene Pulser electroporation system (Bio-Rad) at a voltage of 1.5 kV, resistance of 200 Ω and capacitance of 25 µF. The recombinant cells were selected on Middlebrook 7H10 agar plates containing oleate-albumin-dextrosecatalase (10%) and kanamycin (25 µg/mL). MTB H37Ra (wildtype and recombinant) culture adjusted to an OD of 0.2 units at 600 nm (corresponds to 3 × 10 8 bacteria/mL) was diluted 20 times and treated with in vitro acetylation mixture or rifampicin for 48 h at 37 °C. All the treated and untreated cultures were serially diluted and plated on Middlebrook 7H10 agar (BD Difco TM , Fisher Scientific, USA). After incubation at 37 °C for 3 weeks the colonies were counted and colony forming units (CFU) was calculated.
THP-1 cells (20 × 10 3 ) were differentiated into macrophages by inducing with phorbol 12-myristate 13-acetate (PMA -20 ng/mL) for 24 h and were infected with wild type and recombinant H37Ra at a multiplicity of infection of 20:1. After 4 h, unphagocytosed bacteria were killed by treating with gentamycin (45 μg/mL). Subsequently the cells were treated with isoniazid (6 μg/mL) or rifampicin (1 μg/mL) for 24 h at 37 °C. The cells were lysed with sterile water and plated on Middlebrook 7H10 agar and incubated at 37 °C. The colonies were counted after 3-4 weeks and results were expressed as percentage of survival. 
Gene
Primer sequence (5'-3') Rv2170F
GATC GGATCCTTGGCGATATTCCTCATCGA Rv2170PBENR GATCAAGCTT TTAGAGCGGTAGCGTGCGAC
